Magnetic resonance neurography to study peripheral neuropathies
Brito V, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L
Record ID 32016001117
Spanish
Authors' recommendations:
There is no evidence having shown clinical benefits with the inclusion of magnetic resonance neurography as a diagnostic tool in neuropathies, plexopathies and polyneuropathies of different etiologies.
Very low-quality evidence shows that magnetic resonance neurography might contribute to identifying certain structural abnormalities in the peripheral nerves.
The clinical practice guidelines identified point out magnetic resonance neurography as an imaging technology still at investigational stage; which so far has not proved to be better than the standard diagnostic tests to study neuropathies.
Most coverage policies identified from foreign sponsors do not cover magnetic resonance neurography because they consider it at experimental stage.
In Argentina, magnetic resonance neurography is not included in the Mandatory Medical Program.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Humans
- Magnetic Resonance Imaging
- Magnetic Resonance Spectroscopy
- Peripheral Nervous System Diseases
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.